| Diet quality and depression risk: a systematic review and dose-response meta-analysis of prospective studies M Molendijk, P Molero, FO Sánchez-Pedreño, W Van der Does, ... Journal of affective disorders 226, 346-354, 2018 | 553 | 2018 |
| Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind … V Popova, EJ Daly, M Trivedi, K Cooper, R Lane, P Lim, C Mazzucco, ... American Journal of Psychiatry 176 (6), 428-438, 2019 | 552 | 2019 |
| Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial EJ Daly, MH Trivedi, A Janik, H Li, Y Zhang, X Li, R Lane, P Lim, AR Duca, ... JAMA psychiatry 76 (9), 893-903, 2019 | 479 | 2019 |
| Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review P Molero, JA Ramos-Quiroga, R Martin-Santos, E Calvo-Sánchez, ... CNS drugs 32, 411-420, 2018 | 255 | 2018 |
| A longitudinal analysis of diet quality scores and the risk of incident depression in the SUN Project A Sánchez-Villegas, P Henríquez-Sánchez, M Ruiz-Canela, F Lahortiga, ... BMC medicine 13, 1-12, 2015 | 172 | 2015 |
| Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to … P Molero, F Ortuno, M Zalacain, A Patino-Garcia The Pharmacogenomics Journal 7 (6), 418-426, 2007 | 91 | 2007 |
| Catechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a meta-analysis E Huang, CC Zai, A Lisoway, M Maciukiewicz, D Felsky, AK Tiwari, ... International Journal of Neuropsychopharmacology 19 (5), pyv132, 2016 | 63 | 2016 |
| Relationship between adherence to Dietary Approaches to Stop Hypertension (DASH) diet indices and incidence of depression during up to 8 years of follow-up A Perez-Cornago, A Sanchez-Villegas, M Bes-Rastrollo, A Gea, P Molero, ... Public health nutrition 20 (13), 2383-2392, 2017 | 62 | 2017 |
| Time perception networks and cognition in schizophrenia: A review and a proposal J Gómez, JJ Marín-Méndez, P Molero, Z Atakan, F Ortuño Psychiatry research 220 (3), 737-744, 2014 | 57 | 2014 |
| Preventing the recurrence of depression with a Mediterranean diet supplemented with extra-virgin olive oil. The PREDI-DEP trial: study protocol A Sanchez-Villegas, B Cabrera-Suárez, P Molero, A Gonzalez-Pinto, ... BMC psychiatry 19, 1-7, 2019 | 53 | 2019 |
| Magnesium and mood disorders: systematic review and meta-analysis D Phelan, P Molero, MA Martínez-González, M Molendijk BJPsych open 4 (4), 167-179, 2018 | 41 | 2018 |
| Intake of high-fat yogurt, but not of low-fat yogurt or prebiotics, is related to lower risk of depression in women of the SUN cohort study A Perez-Cornago, A Sanchez-Villegas, M Bes-Rastrollo, A Gea, P Molero, ... The Journal of nutrition 146 (9), 1731-1739, 2016 | 40 | 2016 |
| Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives P Lopez-Garcia, LY Espinoza, PM Santos, J Marin, FO Sanchez-Pedreño Psychiatry research 208 (2), 118-124, 2013 | 38 | 2013 |
| Blunted expansion of regulatory T lymphocytes is associated with increased bacterial translocation in patients with major depressive disorder MA Alvarez-Mon, AM Gomez-Lahoz, A Orozco, G Lahera, MD Sosa-Reina, ... Frontiers in Psychiatry 11, 591962, 2021 | 34 | 2021 |
| Atypical antipsychotics normalize low-gamma evoked oscillations in patients with schizophrenia M Alegre, P Molero, M Valencia, G Mayner, F Ortuño, J Artieda Psychiatry research 247, 214-221, 2017 | 33 | 2017 |
| Dimensions of leisure-time physical activity and risk of depression in the “Seguimiento Universidad de Navarra”(SUN) prospective cohort A Fernandez-Montero, L Moreno-Galarraga, A Sánchez-Villegas, ... BMC psychiatry 20, 1-9, 2020 | 31 | 2020 |
| An investigation of the α1A‐adrenergic receptor gene and antipsychotic‐induced side‐effects PA Saiz, MT Susce, DA Clark, RW Kerwin, P Molero, MJ Arranz, ... Human Psychopharmacology: Clinical and Experimental 23 (2), 107-114, 2008 | 30 | 2008 |
| False positive phencyclidine results caused by venlafaxine PM Santos, P López-García, JS Navarro, AS Fernández, B Sádaba, ... American Journal of Psychiatry 164 (2), 349-349, 2007 | 30 | 2007 |
| Impact of review method on the conclusions of clinical reviews: A systematic review on dietary interventions in depression as a case in point F Thomas-Odenthal, P Molero, W van der Does, M Molendijk PloS one 15 (9), e0238131, 2020 | 27 | 2020 |
| A schizophrenia-like psychotic disorder secondary to an arachnoid cyst remitted with neurosurgical treatment of the cyst GA Baquero, P Molero, J Pla, F Ortuño The open neuroimaging journal 8, 1, 2014 | 25 | 2014 |
felipe ortuñoProfesor Titular Universidad在 unav.es 的电子邮件经过验证
